Table 2 Clinical and pathological data of Cohort #2 (prostate biopsies)
Patients, n | 74 |
|---|---|
Median age, years (range) | 68 (49–85) |
Median PSA (ng/mL) (range) | 18.22 (4.52-542) |
Clinical stage | |
T2 (%) | 48 (64.9) |
T3/T4 (%) | 26 (35.1) |
Gleason score | |
<7 (%) | 30 (40.5) |
≥7 (%) | 44 (59.5) |
Follow up | |
Median (months) (range) | 114.9 (10.3–170.1) |
Patients without remission (%) | 3 (4) |
Biochemical recurrence (%) | 29 (39.2) |
Death due to PCa (%) | 13 (17.6) |
Therapy | |
Surgery (%) | 17 (23.0) |
ADT (%) | 35 (47.3) |
Radiotherapy (%) | 4 (5.4) |
ADT + Radiotherapy (%) | 17 (23.0) |
Radiotherapy + Criotherapy (%) | 1 (1.3) |
CAPRA Score | |
Low-risk (0–2) | 7 (9.5) |
Intermediate-risk (3–5) | 26 (35.1) |
High-risk (6–10) | 41 (55.4) |